Shingles Vaccine

“Routine Vaccination of People 50 Years Old and Older

CDC recommends Shingrix (recombinant zoster vaccine, or RZV) for the prevention of herpes zoster (shingles) and related complications. CDC recommends two doses of Shingrix separated by 2 to 6 months for immunocompetent adults aged 50 years and older:

• Whether or not they report a prior episode of herpes zoster.
• Whether or not they report a prior dose of Zostavax, a shingles vaccine that is no longer available for use in the United States.
• It is not necessary to screen, either verbally or by laboratory serology, for evidence of prior varicella.

Recombinant and adjuvanted vaccines, such as Shingrix, can be administered concomitantly, at different anatomic sites, with other adult vaccines, including COVID-19 vaccines. Coadministration of RZV with adjuvanted influenza vaccine (Fluad) and COVID-19 vaccines is being studied.”
https://www.cdc.gov/vaccines/vpd/shingles/hcp/shingrix/recommendations.html